<DOC>
	<DOCNO>NCT01277900</DOCNO>
	<brief_summary>Type 2 diabetes mellitus ( T2DM ) resolution morbidly obese patient follow bariatric surgery suggest efficacy metabolic surgery non-morbidly obese patient ( body mass index [ BMI ] &lt; 35 kg/m2 ) . Many research show available evidence efficacy safety metabolic surgery resolution T2DM non-morbidly obese . One effective metabolic surgery laparoscopic Roux-en-Y gastric bypass ( LRYGB ) . The investigator intend run 3 year prospective multicenter study evaluate remission efficacy laparoscopic Roux-en-Y gastric bypass Type 2 Diabetes mellitus low BMI ( BMI:25-35 ) Asia area .</brief_summary>
	<brief_title>Efficacy Safety Study Laparoscopic Roux-en-Y Gastric Bypass ( LRYGB ) Treat Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>The study design include 9 bariatric center across Asia region ( China , Korea , Phillipine , Singapore Taiwan ) . Totally 500 patient confirm diagnosis T2DM BMI 25-35 kg/m2 enrol January 2011 December 2013 . Preoperative surgical parameter , blood , biochemistry data , gastrointestinal hormone , upper gastrointestinal study , abdominal ultrasound , peri-operative &amp; postoperative complication record analyze . Patient inclusion criterion : 1 . ) T2DM diagnose 1 year ; 2 . ) age range 30-60 year ; 3 . ) BMI 25-35 kg/m2 ; 4 . ) Patient consent receive long-term follow periodic check . Exclusion criterion : 1 . ) T1DM ; 2 . ) Substance abuse ; 3 . ) Planned pregnancy within 2 year surgery ; 3 . ) Uncontrolled psychiatric disease ; 4 . ) Lost follow . Institutions inclusion criterion : Professional experience 30 LRYGB perform . Trial termination criterion : Surgical mortality 0.5 % first year , Diabetes remission rate failure 20 % one year . All data collect yearly one center . The analysis parameter , statistic brief result inform enrolled institution periodically .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . T2DM diagnose 1 year ; 2 . Age range 3060 year ; 3 . BMI 2535 kg/m2 ; 4 . Patient consent receive longterm follow periodic check . 1 . T1DM ; 2 . Substance abuse ; 3 . Planned pregnancy within 2 year surgery ; 4 . Uncontrolled psychiatric disease ; 5 . Lost follow . Institutions inclusion criterion : Professional experience 30 LRYGB perform . Trial termination criterion : Surgical mortality 0.5 % first year , Diabetes remission rate failure 20 % one year .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>